| Primary |
| Diabetes Mellitus |
17.9% |
| Dyspnoea |
10.7% |
| Pain |
10.7% |
| Type 2 Diabetes Mellitus |
10.7% |
| Agitation |
3.6% |
| Atrial Fibrillation |
3.6% |
| Back Pain |
3.6% |
| Blood Glucose Increased |
3.6% |
| Blood Pressure |
3.6% |
| Convulsion |
3.6% |
| Hypertension |
3.6% |
| Lung Disorder |
3.6% |
| Pneumonia |
3.6% |
| Prophylaxis |
3.6% |
| Renal Disorder |
3.6% |
| Renal Failure |
3.6% |
| Thrombosis Prophylaxis |
3.6% |
| Type 1 Diabetes Mellitus |
3.6% |
|
| Incorrect Dose Administered |
13.3% |
| Acute Generalised Exanthematous Pustulosis |
6.7% |
| Coma |
6.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.7% |
| Hepatitis |
6.7% |
| Hypoglycaemia |
6.7% |
| Hyponatraemia |
6.7% |
| Hypophagia |
6.7% |
| Pruritus |
6.7% |
| Renal Disorder |
6.7% |
| Sensorimotor Disorder |
6.7% |
| Skin Exfoliation |
6.7% |
| Thrombocytopenia |
6.7% |
| Tricuspid Valve Incompetence |
6.7% |
|
| Secondary |
| Product Used For Unknown Indication |
39.8% |
| Type 2 Diabetes Mellitus |
12.0% |
| Diabetes Mellitus |
8.3% |
| Type 1 Diabetes Mellitus |
7.4% |
| Asthma |
4.6% |
| Back Pain |
4.6% |
| Lung Disorder |
4.6% |
| Contraception |
3.7% |
| Agitation |
1.9% |
| Diabetic Neuropathy |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Sedation |
1.9% |
| Thrombosis Prophylaxis |
1.9% |
| Atrial Fibrillation |
0.9% |
| Hypertension |
0.9% |
| Pain |
0.9% |
| Prophylaxis |
0.9% |
| Renal Failure |
0.9% |
| Renal Impairment |
0.9% |
|
| Hypoglycaemia |
19.2% |
| Unintended Pregnancy |
15.4% |
| Sensorimotor Disorder |
11.5% |
| Skin Exfoliation |
11.5% |
| Aortic Valve Incompetence |
3.8% |
| Cardiac Arrest |
3.8% |
| Dyspnoea Exertional |
3.8% |
| Hepatitis |
3.8% |
| Hyperthermia |
3.8% |
| Hyponatraemia |
3.8% |
| Mitral Valve Incompetence |
3.8% |
| Rash |
3.8% |
| Renal Failure |
3.8% |
| Streptococcal Infection |
3.8% |
| Thrombocytopenia |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.0% |
| Drug Use For Unknown Indication |
13.2% |
| Hypertension |
12.9% |
| Bronchitis |
5.0% |
| Type 2 Diabetes Mellitus |
4.7% |
| Pain |
4.4% |
| Infection |
4.1% |
| Immunosuppression |
3.8% |
| Diabetes Mellitus |
3.5% |
| Maternal Exposure During Pregnancy |
3.5% |
| Polytraumatism |
3.5% |
| Prophylaxis |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Type 1 Diabetes Mellitus |
2.2% |
| Anaemia |
1.9% |
| Hypokalaemia |
1.9% |
| Pulmonary Embolism |
1.9% |
| Staphylococcal Infection |
1.9% |
| Anxiety |
1.6% |
| Hypercholesterolaemia |
1.6% |
|
| Vomiting |
15.3% |
| Nausea |
8.5% |
| Thrombocytopenia |
8.5% |
| Posterior Reversible Encephalopathy Syndrome |
6.8% |
| Dyspnoea |
5.1% |
| Haemorrhage Intracranial |
5.1% |
| Rash Erythematous |
5.1% |
| Toxic Epidermal Necrolysis |
5.1% |
| Coma |
3.4% |
| Death |
3.4% |
| Haemoptysis |
3.4% |
| Hepatitis Cholestatic |
3.4% |
| Lung Infection |
3.4% |
| Maternal Exposure During Pregnancy |
3.4% |
| Psoriasis |
3.4% |
| Pulmonary Embolism |
3.4% |
| Renal Failure Acute |
3.4% |
| Syncope |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Tubulointerstitial Nephritis |
3.4% |
|
